Description

GLP-3 RT is a lab-made tri-agonist peptide that works on three hormone receptors: GLP-1, GIP, and glucagon. This triple effect makes it a useful tool for researchers studying metabolism, energy use, and weight control. Scientists use GLP-3 RT to see how the body manages blood sugar, fat use, and heart function in lab tests.

Preclinical and clinical studies, like LY3437943 and TRIUMPH-3, show how GLP-3RT works on several hormone receptors at the same time. This lets researchers watch how tri-agonist peptides affect hormone signals, energy balance, and heart health. These studies give new ideas for treating obesity and related health issues.

NOVAGLO Peptides are manufactured in trusted cGMP-certified facilities located in the USA and worldwide, delivering >99% purity with third-party Certificates of Analysis (COA) completed on every lot.

Peptides are supplied as a high-purity, lyophilized powder for professional research use only. Not for human or animal consumption—intended strictly for laboratory research.
Lyophilized peptides require reconstitution with Bacteriostatic water (sold separately).
Lyophilized peptides should be stored in a cool, dry place. Peptides in a lyophilized form lasts 24 months when stored properly. Once mixed, keep in the fridge (2–8°C) and use within 4–6 weeks after mixing.
Lyophilized peptides are for research use only and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use.
By purchasing, you acknowledge this and that you are an institution or a qualified researcher that is age 21 or older.
Researchers should be familiar with the products they purchase. NOVAGLO does not provide advice on peptide reconstitution or research applications. Please ensure you understand your research needs before ordering.

COA_Retatrutide_quant_20mg

AI detailed analysis and interpretation of the Certificate of Analysis (COA) for Retatrutide 20mg:

Product & Lot Information

•Compound: Retatrutide

•Client: Novaglo Research

•Lot Number: 2025-10-29

•Analysis Date: 2025-11-04

•Method: HPLC-UV-MS (High Performance Liquid Chromatography with UV and Mass Spectrometry)
•CAS Number: 2381089-83-2

Purity Results

•Purity: 99.93%

•The COA shows three detected peaks. The dominant peak (Retatrutide at 7.12 minutes) comprises 99.93% of the total area, indicating very high purity for research use.
•Two minor peaks (0.02% and 0.05%) are present but represent trace impurities well below acceptable thresholds for most research-grade peptides.

Quantity

•Measured Quantity: 24.12 mg per vial

•The quantity was confirmed by HPLC-UV, matching the expected content for the vial, giving confidence in consistency and accuracy.

Identification & Authenticity

•Identity Confirmation: Performed using HPLC-MS.

•Molecular Weight: Expected monoisotopic mass is 4728.47 Da, and the measured mass is 4728.57 Da. The result demonstrates the compound is authentic Retatrutide and the structure is correct.

Quality & Handling Notes

•Salts and sugars may be present in the injectable formulation to improve solubility and act as pH buffers. These are not classified as impurities and are typical in injectable peptide products.

Final Interpretation

This COA for Retatrutide 20mg from Novaglo Research confirms:

•Extremely high purity (99.93%), suitable for demanding research applications.

•Quantity is as labeled, ensuring reliability in dosing.

•Mass spectrometry confirms the identity and authenticity of the peptide.

•The product meets stringent quality standards and is appropriate for research use, with minimal detectable impurities.